Zheng Yi, Lu Min, Ma Lulin, Zhang Shudong, Qiu Min, Ma Xin
Department of Urology, Peking University Third Hospital, Beijing, PR China.
Urol Int. 2013;91(3):350-6. doi: 10.1159/000347191. Epub 2013 Mar 23.
Renal ischemia-reperfusion (I/R) injury is a primary cause of acute renal failure that results in high mortality. This study aimed to investigate the effect of osthole, a natural coumarin derivative, on renal I/R injury in a rat model.
Rats were randomly allocated to the sham operation + vehicle, I/R + vehicle, and I/R + osthole groups. Renal I/R injury was induced by clamping the left renal artery for 45 min followed by 12 h of reperfusion and a contralateral nephrectomy. Osthole (40 mg/kg) was intraperitoneally injected 30 min before inducing I/R. Renal function and histological damage were determined subsequently. Myeloperoxidase activity, monocyte/macrophage infiltration, as well as tumor necrosis factor-α, IL-1β, and activated p38 mitogen-activated protein kinase expression in kidneys were also assessed.
Osthole treatment significantly ameliorated I/R-induced renal functional and morphological injuries. Moreover, osthole treatment attenuated myeloperoxidase activity, monocyte/macrophage infiltration, and tumor necrosis factor-α, IL-1β, and activated p38 mitogen-activated protein kinase expression in kidneys.
Osthole treatment ameliorates renal I/R injury by inhibiting inflammatory responses in kidneys. Thus, osthole may represent a novel practical strategy to prevent renal I/R injury.
肾缺血再灌注(I/R)损伤是急性肾衰竭的主要原因,导致高死亡率。本研究旨在探讨天然香豆素衍生物蛇床子素对大鼠肾I/R损伤的影响。
将大鼠随机分为假手术+赋形剂组、I/R+赋形剂组和I/R+蛇床子素组。通过夹闭左肾动脉45分钟,随后再灌注12小时并进行对侧肾切除术诱导肾I/R损伤。在诱导I/R前30分钟腹腔注射蛇床子素(40mg/kg)。随后测定肾功能和组织学损伤。还评估了肾脏中的髓过氧化物酶活性、单核细胞/巨噬细胞浸润以及肿瘤坏死因子-α、IL-1β和活化的p38丝裂原活化蛋白激酶表达。
蛇床子素治疗显著改善了I/R诱导的肾功能和形态学损伤。此外,蛇床子素治疗减弱了肾脏中的髓过氧化物酶活性、单核细胞/巨噬细胞浸润以及肿瘤坏死因子-α、IL-1β和活化的p38丝裂原活化蛋白激酶表达。
蛇床子素治疗通过抑制肾脏中的炎症反应改善肾I/R损伤。因此,蛇床子素可能代表一种预防肾I/R损伤的新型实用策略。